Affiliation:
1. Pavlov University
2. Nonprofit Partnership «Center for Social Economics»
Abstract
The objective was to analyze the clinical and economic feasibility of using selective methods of lipopolysaccharide (LPS) sorption for sepsis treatment.Materials and methods. A clinical and economic model was used to assess the feasibility of using some technologies of selective lipopolysaccharide sorption. The model was developed in accordance with the current industry standard «Clinical and Economic Research» used in Russia. The target population was patients of 18 years old and older with sepsis. The methodology involved the evaluation of available randomized clinical trials, as well as studies involving data from network meta-analyses and systematic reviews of the use of the studied technologies. The calculation of direct medical and indirect non-medical costs was made with an analysis of the impact on the budget during the first year and on the time horizon for five years.Results. The value of direct and indirect costs was determined when using sorption devices based on Efferon LPS, Toraymyxin, Alteco LPS Adsorber, Toxipak columns. It was shown that among the therapeutic alternatives, the use of the Efferon LPS column had the least burden on the budget.Conclusion. The use of selective lipopolysaccharide sorption technologies in the intensive care program for sepsis patients, although accompanied by an increase in direct and indirect financial costs, leads to budget savings in the medium term. Improving the mechanism for compensating the costs of using this technology is a promising way to improve the outcomes of sepsis treatment.
Publisher
FSBEI HE I.P. Pavlov SPbSMU MOH Russia
Subject
Anesthesiology and Pain Medicine,Critical Care and Intensive Care Medicine,Emergency Medicine
Reference38 articles.
1. Guidelines for comparative clinical and economic evaluation of drugs (new revision). Approved by Edict No.242-od as of 29.12.2018 by Center for Healthcare Quality Assessment and Control of the Ministry of Health of the Russian Federation provides expertise, information and methodological support in implementing healthcare policy. (In Russ.) (Epub.), Available: https://clck.ru/GqdJz (Accessed 28.07.2022) (In Russ.).
2. Paternoster D., Nagi A. Immunomodulation, immunostimulation and extracorporal blood purification for sepsis: prospectives for the technologies use in cardio surgery. Messenger of Anesthesiology and Resuscitation, 2019, vol. 16, no. 2, pp. 96-106. (In Russ.). Doi:10.21292/2078-5658-2019-16-2-96-106.
3. Polushin Yu. S., Dreval R. O., Zabotina A. N. Clinical and economic assessment of the therapy of acute kidney injury in sepsis with continuous combined methods of renal replacement therapy. Messenger of Anesthesiology and Resuscitation, 2021, vol. 18, no 5, pp. 7-20. (In Russ.) Doi: 10.21292/2078-5658-2021-18-5-7-20.
4. Polushin Yu. S., Sokolov D. V., Belousov D. Yu., Cheberda A. E. Pharmaeco-nomic assessment of intermittent and continuous renal replacement therapy. Messenger of Anesthesiology and Resuscitation, 2017, vol. 14, no. 6, pp. 6-20. (In Russ.) Doi: 10.21292/2078-5658-2017-14-6-6-20.
5. Rubtsov M. S., Shukevich D. L. Modern extracorporeal methods for critical conditions caused by systemic inflammatory response (review). Anesteziologiya i Reanimatologiya, 2019, no. 4, pp. 20-30. (In Russ.) Doi:10.17116/anaesthesiology201904120.
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献